On Chemball
My Chemball
+86-571-8627 3270
Hinova Pharma
Hinova Pharma
12 YRS
Sichuan, China
Main Products:
Sichuan, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
ABOUT US
Hinova (688302. SH) is an international and clinical-stage pharmaceutical company focusing on developing new therapeutics for cancers and metabolic syndromes through PROTAC and deuteration technology. We are committed to the discovery and development of innovative drugs with global interests that meet significant clinical needs.
Hinova Pharma has 4 core R&D platforms, which are the PROTAC Platform, Deuteration Platform, Novel Target Discovery and Validation Platform, and Translational Medical Technology Platform. We have submitted more than 300 PCT and national patents, with more than 110 patents granted in China and in the globe, such as the US, EU, and Japan. We have 9 innovative projects in the R&D stage, and 2 National Major Projects of "Significant New Drugs Creation" awarded by the Ministry of Science and Technology of the People’s Republic of China. Hinova Pharma is led by a management team comprised of accomplished experts in both the biotechnology and pharmaceutical industries. Our core team members are mostly from the world's Top 500 pharmaceutical companies, with 2 national-level and several provincial-level experts.
Basic Information
Tax ID
915101000624182263
Country/Region
Sichuan, China
Year Established
2013
Registered Capital
CNY 99.0 Million
Business Type
CDMO
Total Employees
Less than 50 people
Quality Management Certificate
-
Total Annual Revenue
-
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
Build a leading pharmaceutical group to profoundly change the trajectory of health for humanity.
PLANT LOCATION
ORGANIZATION UNIT
5 People
Storage Dept
10 People
Analysis Dept
5 People
Trade Dept
30 People
R&D Dept
20 People
Other Dept
20 People
Production Dept
COMPANY ALBUM
